gullapalli

The tolerability and safety profiles of GSK’s Blenrep combos align with the known profiles of the individual agents involved. Credit: ricochet64/Shutterstock. The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of GSK’s […]

IgA nephropathy results in kidney damage. Credit: Emily frost/Shutterstock. The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance endorsing the use of CSL Vifor’s Filspari (sparsentan) within the National Health Service (NHS) in England

GSK’s antibody has not gained approval for COPD treatment in any other country. Credit: 1take1shot/Shutterstock. GSK has gained approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab), as an add-on maintenance treatment for the

Chronic kidney disease often goes undetected by patients and healthcare professionals. Credit: sasirin pamai/Shutterstock. Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting renal, cardiovascular and metabolic conditions such as chronic kidney disease (CKD), using the latter’s

Paratek has agreed to pay $1 per share if Xhance achieves $150m in net sales in any calendar year before 31 December 2028. Credit: MacroEcon/Shutterstock. Paratek Pharmaceuticals has completed the acquisition of Optinose, valued at almost $330m, broadening its commercial

Lilly’s Kisunla is the first amyloid-targeting therapy for Alzheimer’s registered in the country. Credit: JHVEPhoto/Shutterstock. Eli Lilly and Company has received marketing authorisation from the Australian Therapeutic Goods Administration (TGA) for Kisunla (donanemab) to treat mild cognitive impairment and mild

Orionis is progressing the oncology programmes and cancer immunotherapy pipeline. Credit: kittirat roekburi/Shutterstock. Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech, focusing on the discovery and development of small-molecule monovalent glue medicines for difficult targets in oncology. This

COPD, a prevalent and progressive lung condition, causes restricted airflow and troubled breathing. Credit: NMK-Studio/Shutterstock. Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered workflow solution for improving the management of

The agreement focuses on widening BioNTech’s R&D presence in the country. Credit: Birgit Reitz-Hofmann/Shutterstock. BioNTech has made a grant agreement with the UK government to expand its research and development (R&D) activities for medicines, committing an investment of up to

The manufacturers of Covid-19 vaccines will be asked to carry out placebo-controlled studies in healthy individuals aged 50 to 64 years. Credit: Viacheslav Lopatin/Shutterstock. The US Food and Drug Administration (FDA) is set to restrict Covid-19 booster doses to older